Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral mucosal micrograft transplantation for oral mucosal scar contraction
jRCT1032260621Recruiting
- Sponsor
- Tetsumaruy Murata
- Start
- Oct 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial in Oral submucous fibrosis (OSF), sponsored by Tetsumaruy Murata. Primary endpoints: Incidence and grade of adverse events within 6 months after micrograft transplantation and Safety assessment. Started Oct 2026; status: recruiting.
02
Conditions
Oral submucous fibrosis (OSF)
Beyond the preview
Go deeper on jRCT1032260621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1032260621.